- Home
- PRPH vs ERNA Comparison
PRPH vs ERNA Comparison
Compare PRPH & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- ERNA
- Stock Information
- Founded
- PRPH 1989
- ERNA 2018
- Country
- PRPH United States
- ERNA United States
- Employees
- PRPH N/A
- ERNA N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- PRPH Health Care
- ERNA Health Care
- Exchange
- PRPH Nasdaq
- ERNA Nasdaq
- Market Cap
- PRPH 15.2M
- ERNA 14.2M
- IPO Year
- PRPH 1997
- ERNA N/A
- Fundamental
- Price
- PRPH $0.36
- ERNA $0.18
- Analyst Decision
- PRPH
- ERNA
- Analyst Count
- PRPH 0
- ERNA 0
- Target Price
- PRPH N/A
- ERNA N/A
- AVG Volume (30 Days)
- PRPH 1.9M
- ERNA 465.0K
- Earning Date
- PRPH 05-20-2025
- ERNA 06-13-2025
- Dividend Yield
- PRPH N/A
- ERNA N/A
- EPS Growth
- PRPH N/A
- ERNA N/A
- EPS
- PRPH N/A
- ERNA N/A
- Revenue
- PRPH $5,845,000.00
- ERNA $535,000.00
- Revenue This Year
- PRPH $221.82
- ERNA N/A
- Revenue Next Year
- PRPH N/A
- ERNA N/A
- P/E Ratio
- PRPH N/A
- ERNA N/A
- Revenue Growth
- PRPH N/A
- ERNA 365.22
- 52 Week Low
- PRPH $0.22
- ERNA $0.15
- 52 Week High
- PRPH $4.94
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- PRPH 52.22
- ERNA 35.42
- Support Level
- PRPH $0.23
- ERNA $0.17
- Resistance Level
- PRPH $0.40
- ERNA $0.25
- Average True Range (ATR)
- PRPH 0.05
- ERNA 0.02
- MACD
- PRPH 0.00
- ERNA -0.01
- Stochastic Oscillator
- PRPH 64.00
- ERNA 22.22
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.